Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
12/2003
12/04/2003US20030225099 E.g., 1-(phenylethyl)-(2-(6-(2-pyridin-2-ylethylcarbamoyl)-pyridin-2 -yl)benzyl)carbamate; use as antiarrhythmic active compounds
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/03/2003EP1367052A2 Intermediate for the preparation of carvedilol
12/03/2003EP1367048A2 Compounds generating amine by irradiation with light, photo-setting compositions and photoreactive adhesive compositions
12/03/2003EP1170287B1 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids
12/02/2003US6656934 2-amino-benzoxazinone derivatives for the treatment of obesity
12/02/2003US6656498 Cationic liposomes for gene transfer
12/02/2003CA2097419C Products from the reaction of amine-diol on polyfunctional substances, and their application to cationic and electrodepositable paint compositions
11/2003
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097587A2 Gelling agents
11/27/2003WO2003097572A1 4-alkyl-2-haloaniline derivative and process for producing the same
11/27/2003WO2003014102B1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
11/27/2003US20030220507 Enantioselective transformation of alpha,beta-unsaturated ketones using chiral organic catalysts
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220352 Benzylated PDE4 inhibitors
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030219880 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof
11/26/2003EP1364941A1 Gelling agents
11/26/2003EP1363874A2 Tryptase inhibitors
11/26/2003EP1363612A2 Peptide deformylase inhibitors
11/25/2003US6653501 Using chromatographic process for separating a target chiral compound from its enantiomer in a racemic mixtures; purification
11/25/2003US6653375 Urethane di(meth)acrylate derivatives of 1,3-bis(1-isocyanato-1-methylethyl)benzene
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216576 Methods for preparing CETP inhibitors
11/20/2003US20030216572 Process to produce oxazolidinones
11/20/2003US20030216469 Cyclic amino acid derivatives useful as pharmaceutical agents
11/20/2003US20030216466 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003US20030215801 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/19/2003EP1362846A1 Aminoethanol derivatives
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1132373B1 New derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol
11/19/2003CN1128135C Process for producing alpha-amino ketones
11/18/2003US6649656 Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents
11/18/2003US6649639 Inhibit or block the biological activity of the picornaviral 3C protease.
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/13/2003WO2003093302A2 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
11/13/2003WO2003093287A1 Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002055486A3 Triazene compounds and use thereof
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003US20030212250 Peptides
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030211999 Polypeptides containing gamma-amino acids
11/13/2003US20030211421 Optically active compound and photosensitive resin composition
11/12/2003EP1360172A1 Ppar agonists
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP0760657B1 Novel potent inducers of terminal differentiation and methods of use thereof
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/11/2003US6646156 (Meth)acryloyl-group-containing carbamoyl halides and production process therefor
11/11/2003US6646153 Hydroxyl functional urethanes having a tertiary carbamate bond
11/11/2003US6646150 Reacting 1,3-oxazolidin-5-one derivative with trialkyl-(trifluoromethyl)silane; removing trialkylsilyl group; reductive decyclization
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6645968 Potassium channel openers
11/06/2003WO2003091287A1 Incorporable photoinitiator
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
11/06/2003US20030207344 Ethers and esters of cyanohydrins that contain optically detectable moieties are highly effective for detecting, monitoring, and measuring the activity of enzymes that cause the cleavage of certain types of substrates. The cyanohydrins
11/06/2003US20030207104 Coating composition comprising an acetal-functional binder
11/06/2003CA2483004A1 Incorporable photoinitiator
11/05/2003EP1359141A1 Method of friedel-crafts acylation of anilides
11/05/2003EP1359136A2 Polymeric resin compounds and their preparation
11/05/2003EP1358244A2 Polyols containing carboxyl groups and production thereof
11/05/2003EP1358197A1 Hybrid protecting groups
11/05/2003EP0682660B1 Synthesis of taxol, analogs and intermediates with variable a-ring side chains
11/05/2003CN1454207A Fluoroalkyloxy dispersant
11/04/2003US6642180 Biphenyl-substituted cyclic ketoenols as pesticides
10/2003
10/30/2003WO2003089404A1 Naphthalene amides as potassium channel openers
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003US20030204104 Perfluoroalkylated aniline compound and process for producing the same
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030203975 Such as complex of amino acid/peptide and 1-(2-hydroxyethylamino)anthracene-9,10-dione
10/30/2003US20030203944 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
10/30/2003US20030203898 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/29/2003EP1357112A1 Novel functional peptide nucleic acid monomer and process for producing the same
10/29/2003EP1357107A1 Indanones and carbamate, and their use in the preparation of arthropodicial oxadiazines
10/29/2003EP1355876A1 Methods of chemical synthesis of phenolic nitrogen mustard prodrugs
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1178957B1 Monomer and polymerization process
10/29/2003EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
10/29/2003CN1125812C Novel modifications to 2-amino-4 (4-fluorobenzylamino)-1-ethoxy. carbonyl-aminobenzene and processes for preparing said compound
10/28/2003US6639097 Fungicides
10/28/2003US6639094 Process for producing α-aminoketone derivatives
10/28/2003CA2269897C Aminophenol derivatives and their use in cosmetics
10/28/2003CA2249786C Difluoro statone analogs
10/28/2003CA2154558C Process for preparing c-substituted diethylene triamines
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087055A1 Improved cc-1065 analog synthesis
10/23/2003WO2003087046A1 Novel aminotetraline compounds for use in mch receptor related disorders
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2002046128A3 Quaternary amino acids on solid supports
10/23/2003US20030199580 Condensation of amine derivative with carboxylic acid derivatives to afford intermediate compound, followed by cyclization of intermediate compound in presence of acid; hyopoglycemic action
10/23/2003US20030199578 Naphthalene amides as potassium channel openers
10/23/2003US20030199577 For preparation of DNA chips and bio-chips, where fixation of desired molecules on surface and study of surface is easy; prepared by reacting amine groups of aminosilylated surface of substrate with novel carbamate compound
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 157